Ray McDermott
Cancer Trials Ireland(IE)St. Vincent's University Hospital(IE)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Cancer Immunotherapy and Biomarkers, PARP inhibition in cancer therapy, Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics
Most-Cited Works
- → Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma(2015)5,839 cited
- → Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma(2018)4,536 cited
- → Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma(2019)3,317 cited
- → Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study(2017)2,758 cited
- → Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer(2018)2,022 cited
- → Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer(2019)1,551 cited